131
Views
6
CrossRef citations to date
0
Altmetric
Clinical Focus: Cardiometabolic Conditions - Original Research

Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome

, , , , &
Pages 805-809 | Received 03 Jun 2016, Accepted 29 Sep 2016, Published online: 12 Oct 2016

References

  • Kurl S, Laukkanen JA, Niskanen L, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke. 2006;37:806–811.
  • Meng W, Zhang C, Zhang Q, et al. Association between leukocyte and metabolic syndrome in urban han chinese: A longitudinal cohort study. PLoS One. 2012;7:e49875.
  • Vollenweider P, Von Eckardstein A, Widmann C. Hdls, diabetes, and metabolic syndrome. Handb Exp Pharmacol. 2015;224:405–421.
  • Dandona P, Aljada A, Chaudhuri A, et al. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448–1454.
  • Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res. 2008;31:1283–1291.
  • Ford ES. The metabolic syndrome and c-reactive protein, fibrinogen, and leukocyte count: findings from the third national health and nutrition examination survey. Atherosclerosis. 2003;168:351–358.
  • Nagasawa N, Tamakoshi K, Yatsuya H, et al. Association of white blood cell count and clustered components of metabolic syndrome in japanese men. Circ J. 2004;68:892–897.
  • Ohshita K, Yamane K, Hanafusa M, et al. Elevated white blood cell count in subjects with impaired glucose tolerance. Diabetes Care. 2004;27:491–496.
  • Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care. 2004;27:216–222.
  • Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97:3A–11A.
  • Pei D, Hsia TL, Chao TT, et al. Gamma-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly. Saudi J Gastroenterol. 2015;21:158–164.
  • Hsu CY, McCulloch CE, Iribarren C, et al. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21–28.
  • Mochizuki K, Miyauchi R, Misaki Y, et al. Associations between leukocyte counts and cardiovascular disease risk factors in apparently healthy japanese men. J Nutr Sci Vitaminol (Tokyo). 2012;58:181–186.
  • Tanigawa T, Iso H, Yamagishi K, et al. Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged japanese men. Atherosclerosis. 2004;173:295–300.
  • Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640–1645.
  • Chen W, Srinivasan SR, Xu J, et al. Black-white divergence in the relation of white blood cell count to metabolic syndrome in preadolescents, adolescents, and young adults: the bogalusa heart study. Diabetes Care. 2010;33:2474–2476.
  • Lao XQ, Thomas NG, Jiang C, et al. White blood cell count and the metabolic syndrome in older chinese: the guangzhou biobank cohort study. Atherosclerosis. 2008;201:418–424.
  • Hagita S, Osaka M, Shimokado K, et al. Adipose inflammation initiates recruitment of leukocytes to mouse femoral artery: Role of adipo-vascular axis in chronic inflammation. PLoS One. 2011;6:e19871.
  • Feingold KR, Doerrler W, Dinarello CA, et al. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology. 1992;130:10–16.
  • Elkind MS, Cheng J, Boden-Albala B, et al. Northern manhattan stroke S. Elevated white blood cell count and carotid plaque thickness: the northern manhattan stroke study. Stroke. 2001;32:842–849.
  • Uysal KT, Wiesbrock SM, Marino MW, et al. Protection from obesity-induced insulin resistance in mice lacking tnf-alpha function. Nature. 1997;389:610–614.
  • Hirosumi J, Tuncman G, Chang L, et al. A central role for jnk in obesity and insulin resistance. Nature. 2002;420:333–336.
  • Shankar A, Klein BE, Klein R. Relationship between white blood cell count and incident hypertension. Am J Hypertens. 2004;17:233–239.
  • Nakanishi N, Suzuki K, Tatara K. White blood cell count and clustered features of metabolic syndrome in japanese male office workers. Occup Med (Chic Ill). 2002;52:213–218.
  • Marchesini G, Avagnina S, Barantani EG, et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest. 2005;28:333–339.
  • Zapolski T, Wacinski P, Kondracki B, et al. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. Kardiol Pol. 2011;69:319–326.
  • Kang DH, Park SK, Lee IK, et al. Uric acid-induced c-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553–3562.
  • Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41:1287–1293.
  • Carnethon MR, Fortmann SP, Palaniappan L, et al. Risk factors for progression to incident hyperinsulinemia: the atherosclerosis risk in communities study, 1987-1998. Am J Epidemiol. 2003;158:1058–1067.
  • Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183–1190.
  • Nakanishi N, Okamoto M, Yoshida H, et al. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type ii diabetes in japanese male office workers. Eur J Epidemiol. 2003;18:523–530.
  • Niskanen LK, Laaksonen DE, Nyyssonen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study. Arch Intern Med. 2004;164:1546–1551.
  • Church TS, Finley CE, Earnest CP, et al. Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. Int J Obes Relat Metab Disord. 2002;26:805–813.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.